Literature DB >> 12829557

Comparison of methods to identify individuals at increased risk of coronary disease from the general population.

S Wilson1, A Johnston, J Robson, N Poulter, D Collier, G Feder, M J Caulfield.   

Abstract

OBJECTIVES: To evaluate the guidelines on measurement of cholesterol in the national service framework for coronary heart disease and to compare alternative strategies for identifying people at high risk of coronary disease in the general population.
DESIGN: Comparison of methods (national service framework criteria, Sheffield tables, age threshold of 50 years, estimated risk assessment using fixed cholesterol values) for identifying people with a 10 year coronary event risk of 15% or greater.
SETTING: Health survey for England 1998.
SUBJECTS: 6307 people aged between 30 and 74 years with no history of myocardial infarction, stroke, or angina. MAIN OUTCOME MEASURES: Proportion of the total population selected for measurement of cholesterol and proportion of people at 15% or greater risk identified.
RESULTS: The national service framework guidelines selected 43.4% (95% confidence interval 42.2% to 44.6%) of the study population for cholesterol measurement and identified 81.2% (80.2% to 82.2%) of those at 15% or greater risk. The Sheffield tables selected 73.1% (72.0% to 74.2%) for cholesterol measurement and identified 99.91% (99.83% to 99.99%) of those at 15% or greater risk. An age threshold of 50 years selected 46.3% (45.1% to 47.5%) for cholesterol measurement and identified 92.8% (92.1% to 93.4%) of those at 15% or greater risk. Estimated risk assessments using fixed cholesterol values selected 17.8% (16.8% to 18.7%) for cholesterol measurement and identified 75.9% (74.8% to 76.9%) of those at 15% or greater risk.
CONCLUSION: Measuring the cholesterol concentration of everyone aged 50 years and over is a simple and efficient method of identifying people at high risk of coronary disease in the general population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829557      PMCID: PMC162258          DOI: 10.1136/bmj.326.7404.1436

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Authors:  E J Wallis; L E Ramsay; I Ul Haq; P Ghahramani; P R Jackson; K Rowland-Yeo; W W Yeo
Journal:  BMJ       Date:  2000-03-11

2.  Estimating cardiovascular risk for primary prevention: outstanding questions for primary care.

Authors:  J Robson; K Boomla; B Hart; G Feder
Journal:  BMJ       Date:  2000-03-11

3.  Predicting coronary risk in the general population--is it necessary to measure high-density lipoprotein cholesterol?

Authors:  Sarah Wilson; Atholl Johnston; John Robson; Neil R Poulter; David J Collier; Gene S Feder; Mark J Caulfield
Journal:  J Cardiovasc Risk       Date:  2003-04

4.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

5.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

6.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Authors:  Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

Review 7.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

8.  Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores.

Authors:  M W Knuiman; H T Vu
Journal:  J Epidemiol Community Health       Date:  1997-10       Impact factor: 3.710

9.  Ischemic heart disease and stroke mortality in African-American, Hispanic, and non-Hispanic white men and women, 1985 to 1991.

Authors:  A J Karter; J M Gazzaniga; R D Cohen; M L Casper; B D Davis; G A Kaplan
Journal:  West J Med       Date:  1998-09
  9 in total
  3 in total

1.  Methods to identify increased risk of coronary disease in the general population: conclusion is oversimplification.

Authors:  Gerd Assmann; Paul Cullen; Helmut Schulte
Journal:  BMJ       Date:  2003-09-13

2. 

Authors:  V Manger Cats
Journal:  Neth Heart J       Date:  2003-09       Impact factor: 2.380

3.  Commentary: point. Blood pressure-lowering treatment should be offered to all patients regardless of blood pressure.

Authors:  Richard J McManus; Jonathan Mant
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.